AnaSpec

- Model AS-55581 - Human recombinant a-Synuclein (1-140), biotin labeled - 200 µg

From

0

Parkinson's disease is predominantly a movement disorder resulting from degeneration of dopaminergic neurons in the substantia nigra. The cause of the disease is unknown, but substantial evidence suggests that the aggregation of α-synuclein is a critical step in the etiology of Parkinson's disease (PD). α-Synuclein is an abundant brain protein of 140 residues that is present in high concentration at presynaptic terminals and is found in both soluble and membrane-associated fractions of the brain. Several possible functions have been suggested for α-synuclein, and it also appears to be involved in vesicle release and trafficking. In vitro incubation in the presence of a specific amount of salt (i.e. 0.1M NaCl) with agitation shows α-synuclein forming fibrilous structure.

Specification

Chemistry

  • UniProt number : P37840
  • Molecular Mass/ Weight : 14.5 kDa

Modification

  • Conjugation type : Biotins
  • Modification Name : Biotin
  • Conjugation : Conjugated

Quantity & Purity

  • Concentration : 1 mg/ml
  • Purification Method : Purified

Storage & stability

  • Form : In solution
  • Storage Buffer : 10 mM sodium phosphate buffer (pH=7.4)
  • Storage Conditions : Store at -80°C. Avoid repeated freeze-thaw cycles.

Activity

  • Application : Aggregation/Fibrillation ELISA Western Blotting
  • Biomarker Target : Synuclein
  • Specificity : human a-synuclein (1-140)
  • Research Area : Neuroscience
  • Sub-category Research Area : Parkinson's Disease
  • Usage : Research use

Source

  • Host : E. coli
  • Source / Species : human

Customer reviews

No reviews were found for AnaSpec - Model AS-55581 - Human recombinant a-Synuclein (1-140), biotin labeled - 200 µg. Be the first to review!